Docosahexaenoic acid sensitizes colon cancer cells to sulindac sulfide-induced apoptosis

Oncology Reports

Volumn 27, Issue 6, 2012, Pages 2023-2030

  Lim, Soo Jeong ^a   Lee, Eunmyong ^a   Lee, Eun Hye ^a   Kim, Soo Yeon ^a   Cha, Jun Hyung ^b   Choi, Hwanho ^a   Park, Wanseo ^c   Choi, Hyeon Kyeom ^d   Ko, Seong Hee ^d   Kim, So Hee ^d  

^a Sejong University   (South Korea)

^b Hyundai High School   (South Korea)

^c National Cancer Center   (South Korea)

^d Gangneung Wonju National University   (South Korea)

Author keywords

Apoptosis; Colon cancer; Death receptor; Docosahexaenoic acid; Sulindac

Indexed keywords

CASPASE 8; DEATH RECEPTOR 5; DOCOSAHEXAENOIC ACID; POLY(ADENOSINE DIPHOSPHATE RIBOSE); SULINDAC SULFIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; COLON CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR XENOGRAFT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; CASPASE 8; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; DOCOSAHEXAENOIC ACIDS; DRUG SYNERGISM; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; OLIGOPEPTIDES; POLY(ADP-RIBOSE) POLYMERASES; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SULINDAC; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84860734147     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1706     Document Type: Article

References (26)

1. Piazza GA, Keeton AB, Tinsley HN, Gary BD, Whitt JD, Mathew B, Thaiparambil J, Coward L, Gorman G, Li Y, Sani B, Hobrath JV, Maxuitenko YY and Reynolds RC: A novel sulindac derivative that does not inhibit cyclooxygenases but potently inhibits colon tumor cell growth and induces apoptosis with antitumor activity. Cancer Prev Res (Phila) 2: 572-580, 2009.
2. Shi J, He Q, An J, Sun H, Huang Y and Sheikh MS: Sulindac sulfide differentially induces apoptosis in Smac-proficient and -deficient human colon cancer cells. Mol Cell Pharmacol 1: 92-97, 2009.
3. Tuma R: Drugs to prevent colon cancer show promise, but hurdles remain for chemoprevention. J Natl Cancer Inst 100: 764-766, 2008.
4. Huang Y, He Q, Hillman MJ, Rong R and Sheikh MS: Sulindac sulfide-induced apoptosis involves death receptor 5 and the caspase 8-dependent pathway in human colon and prostate cancer cells. Cancer Res 61: 6918-6924, 2001. (Pubitemid 32896519)
5. Zhang L, Yu J, Park BH, Kinzler KW and Vogelstein B: Role of BAX in the apoptotic response to anticancer agents. Science 290: 989-992, 2000.
6. Sinicrope FA and Penington RC: Sulindac sulfide-induced apoptosis is enhanced by a small-molecule Bcl-2 inhibitor and by TRAIL in human colon cancer cells overexpressing Bcl-2. Mol Cancer Ther 4: 1475-1483, 2005. (Pubitemid 41556429)
7. Ohtsuki T, Kikuchi H, Koyano T, Kowithayakorn T, Sakai T and Ishibashi M: Death receptor 5 promoter-enhancing compounds isolated from Catimbium speciosum and their enhancement effect on TRAIL-induced apoptosis. Bioorg Med Chem 17: 6748-6754, 2009.
8. Elrod HA and Sun SY: Modulation of death receptors by cancer therapeutic agents. Cancer Biol Ther 7: 163-173, 2008. (Pubitemid 351590418)
9. Serini S, Piccioni E, Merendino N and Calviello G: Dietary polyunsaturated fatty acids as inducers of apoptosis: implications for cancer. Apoptosis 14: 135-152, 2009.
10. Habermann N, Schon A, Lund EK and Glei M: Fish fatty acids alter markers of apoptosis in colorectal adenoma and adenocarcinoma cell lines but fish consumption has no impact on apoptosis-induction ex vivo. Apoptosis 15: 621-630, 2010.
11. Engelbrecht AM, Toit-Kohn JL, Ellis B, Thomas M, Nell T and Smith R: Differential induction of apoptosis and inhibition of the PI3-kinase pathway by saturated, monounsaturated and polyunsaturated fatty acids in a colon cancer cell model. Apoptosis 13: 1368-1377, 2008.
12. Kang KS, Wang P, Yamabe N, Fukui M, Jay T and Zhu BT: Docosahexaenoic acid induces apoptosis in MCF-7 cells in vitro and in vivo via reactive oxygen species formation and caspase-8 activation. PLoS One 5: e10296, 2010.
13. Biondo PD, Brindley DN, Sawyer MB and Field CJ: The potential for treatment with dietary long-chain polyunsaturated n-3 fatty acids during chemotherapy. J Nutr Biochem 19: 787-796, 2008.
14. Maheo K, Vibet S, Steghens JP, Dartigeas C, Lehman M, Bougnoux P and Gore J: Differential sensitization of cancer cells to doxorubicin by DHA: a role for lipoperoxidation. Free Radic Biol Med 39: 742-751, 2005. (Pubitemid 41139889)
15. Slagsvold JE, Pettersen CH, Storvold GL, Follestad T, Krokan HE and Schonberg SA: DHA alters expression of target proteins of cancer therapy in chemotherapy resistant SW620 colon cancer cells. Nutr Cancer 62: 611-621, 2010.
16. Giros A, Grzybowski M, Sohn VR, Pons E, Fernandez-Morales J, Xicola RM, Sethi P, Grzybowski J, Goel A, Boland CR, Gassull MA and Llor X: Regulation of colorectal cancer cell apoptosis by the n-3 polyunsaturated fatty acids Docosahexaenoic and Eicosapentaenoic. Cancer Prev Res (Phila) 2: 732-742, 2009.
17. Hofmanova J, Vaculova A and Kozubik A: Polyunsaturated fatty acids sensitize human colon adenocarcinoma HT-29 cells to death receptor-mediated apoptosis. Cancer Lett 218: 33-41, 2005. (Pubitemid 40082699)
18. Vaculova A, Hofmanova J, Andera L and Kozubik A: TRAIL and docosahexaenoic acid cooperate to induce HT-29 colon cancer cell death. Cancer Lett 229: 43-48, 2005. (Pubitemid 41262538)
19. Liu X, Yue P, Zhou Z, Khuri FR and Sun SY: Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells. J Natl Cancer Inst 96: 1769-1780, 2004. (Pubitemid 39654571)
20. Kim MJ, Kim SH and Lim SJ: Comparison of the apoptosis-inducing capability of sulforaphane analogues in human colon cancer cells. Anticancer Res 30: 3611-3619, 2010.
21. Jang TJ, Kang HJ, Kim JR and Yang CH: Non-steroidal anti-inflammatory drug activated gene (NAG-1) expression is closely related to death receptor-4 and -5 induction, which may explain sulindac sulfide induced gastric cancer cell apoptosis. Carcinogenesis 25: 1853-1858, 2004.
22. Soh JW, Mao Y, Kim MG, Pamukcu R, Li H, Piazza GA, Thompson WJ and Weinstein IB: Cyclic GMP mediates apoptosis induced by sulindac derivatives via activation of c-Jun NH2-terminal kinase 1. Clin Cancer Res 6: 4136-4141, 2000.
23. Sung B, Ravindran J, Prasad S, Pandey MK and Aggarwal BB: Gossypol induces death receptor-5 through activation of the ROS-ERK-CHOP pathway and sensitizes colon cancer cells to TRAIL. J Biol Chem 285: 35418-35427, 2010.
24. Yang H, Park SH, Choi HJ and Moon Y: The integrated stress response-associated signals modulates intestinal tumor cell growth by NSAID-activated gene 1 (NAG-1/MIC-1/PTGF-beta). Carcinogenesis 31: 703-711, 2010.
25. Chapkin RS, McMurray DN, Davidson LA, Patil BS, Fan YY and Lupton JR: Bioactive dietary long-chain fatty acids: emerging mechanisms of action. Br J Nutr 100: 1152-1157, 2008.
26. Yamagami T, Porada CD, Pardini RS, Zanjani ED and Almeida-Porada G: Docosahexaenoic acid induces dose dependent cell death in an early undifferentiated subtype of acute myeloid leukemia cell line. Cancer Biol Ther 8: 331-337, 2009.